Molecular imaging with 18 F-FDG PET has been proven useful in the management of colorectal
cancer. F-FDG PET plays a pivotal role in staging before surgical resection of recurrent …

For several years, molecular imaging with 18 F‐fluorodeoxyglucose positron emission
tomography (FDG‐PET) has become part of the standard of care in presurgical staging of patients …

New antitumor agents have resulted in significant survival benefits for cancer patients.
However, several agents may have serious cardiovascular side effects. Left ventricular ejection …

PURPOSE: Each pathological stage of non-small cell lung cancer (NSCLC) consists of a
heterogeneous population containing patients at much higher risk than others. Noninvasive …

Purpose Since 18 F-fluorodeoxyglucose (FDG) accumulates in neoplastic cells and in activated
inflammatory cells, positron emission tomography (PET) with FDG could be valuable in …

The use of dynamic 18 F-FDG PET to determine changes in tumor metabolism requires tumor
and plasma time–activity curves. Because arterial sampling is invasive and laborious, our …

The aim of this prospective study was to evaluate the value of 18 F-FDG PET for the assessment
of chemotherapy response in patients with non–small cell lung cancer. Furthermore, …

The potential of 18 F-FDG PET changes was evaluated for prediction of response to
concomitant chemoradiotherapy in patients with locally advanced non–small cell lung cancer (…

Purpose Quantitative SPECT-CT is a modality of growing importance with initial developments
in post radionuclide therapy dosimetry, and more recent expansion into bone, cardiac …

Introduction Biological features of non–small-cell lung carcinomas (NSCLCs) are important
determinants for prognosis. In this study, differences in glucose metabolism between adeno- …